The upgrade in the price target by a reputable analyst like Mike Matson from Needham is a strong positive signal for Boston Scientific. It suggests a bullish outlook on the company's future performance and potential for stock price appreciation. Such analyst actions often lead to short-term positive momentum in the stock as market participants adjust their valuations based on the new information.